Condition
Major Depressive Episode clinical trials and research
As of November 12, 2026, Find a Trial lists 17 Major Depressive Episode clinical trials that are recruiting, at sites in 5 countries (most in France (6), Canada (4), United States (3)). 2 were first registered in the last 30 days. By phase: Phase 3 (2), Phase 1 (1). The most active sponsors are Assistance Publique - Hôpitaux de Paris (3), Istanbul University - Cerrahpasa (2), Technical University of Munich (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 17Clinical trials
- 2New in 30 days
- 5Countries
Newest Major Depressive Episode clinical trials
All recruiting trials (17)
-
Sensation Seeking and TMS Response in TRD: Does Personality Shape Treatment Outcomes?
This real-world study tests whether people with treatment-resistant depression who have higher sensation-seeking traits respond differently to TMS treatment.
-
Remote monitoring for adults with depression using ThIA Suivi
This study tests whether adding the ThIA Suivi remote monitoring tool to usual psychiatric care helps adults with depression feel more improved after 3 months compared with standard care alone.
-
EEG microstates and inflammatory markers in treatment-resistant depression patients undergoing ECT
This study tests how electroconvulsive therapy affects brain activity patterns seen in EEG and inflammatory biomarkers in adults with treatment-resistant major depression.
-
EEG microstates and inflammatory biomarkers in older adults with major depression receiving ECT
This study tests how ECT affects brain wave patterns and inflammatory markers in people 55 and older with major depression.
-
Sleep-to-Mood in Depression: Home-based tDCS
This study tests whether home-based tDCS for adults with moderate depression helps sleep improve and whether better sleep is linked to mood improvements.
-
Light therapy response in unipolar and bipolar major depressive episodes
This study tests whether light therapy helps adults with a major depressive episode respond to treatment, including those with unipolar or bipolar depression.
-
At‑home tDCS maintenance for depression
This pilot tests whether an at-home transcranial direct current stimulation (tDCS) program can help adults with depression maintain improvements achieved during inpatient treatment.
-
Digital health tools for adults with treatment-resistant depression
This study is testing if digital health tools, like apps and wearable devices, can help adults with treatment-resistant depression track their symptoms and treatment responses while they receive care.
-
Coach-guided personalized depression risk communication to lower the chance of a major depressive episode
This trial will test whether a coach-guided tool that shows your personalized depression risk and recommends evidence-based self-help steps can lower the chance of a major depressive episode in adults at high risk.
-
New treatment for depression in adolescents using brain stimulation
This study is testing a new brain stimulation treatment for depression in teens aged 14-19 who haven't tried antidepressants before, to see if it helps them feel better.
-
Comparing Ketamine and Placebo for Severe Depression Treatment
This study tests if intravenous ketamine can help people with severe depression feel better faster than traditional antidepressants.
-
Imaging brain activity in patients with depression after COVID-19
This study is trying to see how COVID-19 might affect brain activity in people who have depression after their infection.
-
Measuring blood metabolites during electroconvulsive therapy for depression
This study is testing if changes in blood substances during electroconvulsive therapy can help predict how well the treatment works for people with major depression or bipolar disorder.
-
Cohort of patients with major depressive episodes focusing on sleep and biological rhythms
This study is trying to find out if certain sleep and biological markers can help identify different types of depression in patients to improve how we diagnose and treat it.
-
Comparing two types of brain stimulation for treatment-resistant depression
This study is testing if a new type of brain stimulation can help people with treatment-resistant depression just as well as a current method they already use.
-
Registry for patients with treatment-resistant depression and OCD receiving interventional therapies
This study is testing different treatments like ECT, TMS, and ketamine to see how they help people with treatment-resistant depression and OCD feel better.
-
Using buprenorphine to reduce severe suicidal thoughts in depressed patients
This study is testing if low doses of buprenorphine can help reduce severe suicidal thoughts in people experiencing major depression.
Related topics
Quick answers
How many Major Depressive Episode clinical trials are recruiting right now?
17, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in France (6 trials), Canada (4 trials), United States (3 trials), Turkey (Türkiye) (2 trials), Germany (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.